175 related articles for article (PubMed ID: 9134274)
1. Effects of imidapril therapy on endogenous fibrinolysis in patients with recent myocardial infarction.
Soejima H; Ogawa H; Yasue H; Suefuji H; Kaikita K; Nishiyama K
Clin Cardiol; 1997 May; 20(5):441-5. PubMed ID: 9134274
[TBL] [Abstract][Full Text] [Related]
2. The effects of the angiotensin-converting enzyme inhibitor imidapril on plasma plasminogen activator inhibitor activity in patients with acute myocardial infarction.
Oshima S; Ogawa H; Mizuno Y; Yamashita S; Noda K; Saito T; Sumida H; Suefuji H; Kaikita K; Soejima H; Yasue H
Am Heart J; 1997 Nov; 134(5 Pt 1):961-6. PubMed ID: 9398110
[TBL] [Abstract][Full Text] [Related]
3. Does long-term angiotensin converting enzyme inhibition affect the concentration of tissue-type plasminogen activator-plasminogen activator inhibitor-1 in the blood of patients with a previous myocardial infarction.
Pedersen OD; Gram J; Jeunemaitre X; Billaud E; Jespersen J
Coron Artery Dis; 1997 May; 8(5):283-91. PubMed ID: 9285181
[TBL] [Abstract][Full Text] [Related]
4. Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. HEART Study Investigators.
Vaughan DE; Rouleau JL; Ridker PM; Arnold JM; Menapace FJ; Pfeffer MA
Circulation; 1997 Jul; 96(2):442-7. PubMed ID: 9244210
[TBL] [Abstract][Full Text] [Related]
5. Relationship between serum angiotensin-converting enzyme activity and plasma plasminogen activator inhibitor activity in patients with recent myocardial infarction.
Moriyama Y; Ogawa H; Oshima S; Arai H; Takazoe K; Shimomura H; Hirai N; Suefuji H; Soejima H; Nishiyama K; Misumi K; Yasue H
Coron Artery Dis; 1998; 9(10):691-6. PubMed ID: 9894621
[TBL] [Abstract][Full Text] [Related]
6. Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarction.
Wright RA; Flapan AD; Alberti KG; Ludlam CA; Fox KA
J Am Coll Cardiol; 1994 Jul; 24(1):67-73. PubMed ID: 8006284
[TBL] [Abstract][Full Text] [Related]
7. Fibrinolysis and insulin sensitivity in imidapril and candesartan (FISIC study) recipients with hypertension.
Fogari R; Zoppi A; Salvadeo SA; Mugellini A; Lazzari P; Santoro T; Derosa G
Hypertens Res; 2011 Apr; 34(4):509-15. PubMed ID: 21179101
[TBL] [Abstract][Full Text] [Related]
8. Leptin levels are not affected by enalapril treatment after an uncomplicated myocardial infarction, but associate strongly with changes in fibrinolytic variables in men.
Eriksson MA; Söderberg S; Nilsson TK; Eriksson M; Boman K; Jansson JH
Scand J Clin Lab Invest; 2020 Jul; 80(4):303-308. PubMed ID: 32125188
[TBL] [Abstract][Full Text] [Related]
9. Effects of angiotensin-converting enzyme inhibitor on plasma B-type natriuretic peptide levels in patients with acute myocardial infarction.
Mizuno Y; Yasue H; Oshima S; Yoshimura M; Ogawa H; Morita E; Saito T; Yamashita S; Noda K; Sumida H; Motoyama T; Soejima H; Nakao K
J Card Fail; 1997 Dec; 3(4):287-93. PubMed ID: 9547443
[TBL] [Abstract][Full Text] [Related]
10. Effect on the atherogenic marker plasminogen activator inhibitor type-1 of addition of the ACE inhibitor imidapril to angiotensin II type 1 receptor antagonist therapy in hypertensive patients with abnormal glucose metabolism: a prospective cohort study in primary care.
Yajima K; Shimada A; Hirose H; Oikawa Y; Yamada S; Meguro S; Irie J; Irie S
Clin Drug Investig; 2009; 29(12):811-9. PubMed ID: 19888787
[TBL] [Abstract][Full Text] [Related]
11. Captopril reduced plasminogen activator inhibitor activity in patients with acute myocardial infarction.
Moriyama Y; Ogawa H; Oshima S; Takazoe K; Honda Y; Hirashima O; Arai H; Sakamoto T; Sumida H; Suefuji H; Kaikita K; Yasue H
Jpn Circ J; 1997 Apr; 61(4):308-14. PubMed ID: 9152782
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis.
Katoh M; Egashira K; Mitsui T; Chishima S; Takeshita A; Narita H
J Mol Cell Cardiol; 2000 Jan; 32(1):73-83. PubMed ID: 10652192
[TBL] [Abstract][Full Text] [Related]
13. High- versus low-dose ACE inhibition in chronic heart failure: a double-blind, placebo-controlled study of imidapril.
van Veldhuisen DJ; Genth-Zotz S; Brouwer J; Boomsma F; Netzer T; Man In 'T Veld AJ; Pinto YM; Lie KI; Crijns HJ
J Am Coll Cardiol; 1998 Dec; 32(7):1811-8. PubMed ID: 9857856
[TBL] [Abstract][Full Text] [Related]
14. Imidapril, an angiotensin-converting enzyme inhibitor, inhibits thrombosis via reduction in aortic plasminogen activator inhibitor type-1 levels in spontaneously hypertensive rats.
Mitsui T; Chishima S; Odawara A; Ohtani A
Biol Pharm Bull; 1999 Aug; 22(8):863-5. PubMed ID: 10480327
[TBL] [Abstract][Full Text] [Related]
15. Improved fibrinolysis after one year of treatment with enalapril in men and women with uncomplicated myocardial infarction.
Boman KO; Jansson JH; Nyhlén KA; Nilsson TK
Thromb Haemost; 2002 Feb; 87(2):311-6. PubMed ID: 11859853
[TBL] [Abstract][Full Text] [Related]
16. Role of angiotensin II in plasma PAI-1 changes induced by imidapril or candesartan in hypertensive patients with metabolic syndrome.
Fogari R; Zoppi A; Mugellini A; Maffioli P; Lazzari P; Derosa G
Hypertens Res; 2011 Dec; 34(12):1321-6. PubMed ID: 21814211
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetic analysis of the effect of angiotensin-converting enzyme inhibitor on restenosis after percutaneous transluminal coronary angioplasty.
Okamura A; Ohishi M; Rakugi H; Katsuya T; Yanagitani Y; Takiuchi S; Taniyama Y; Moriguchi K; Ito H; Higashino Y; Fujii K; Higaki J; Ogihara T
Angiology; 1999 Oct; 50(10):811-22. PubMed ID: 10535720
[TBL] [Abstract][Full Text] [Related]
18. Effect of ACE inhibition on the fibrinolytic system in patients requiring coronary artery bypass grafting.
Walter T; Szabo S; Kazmaier S; Suselbeck T; Borggrefe M; Hoffmeister HM
Thorac Cardiovasc Surg; 2009 Sep; 57(6):368-71. PubMed ID: 19707983
[TBL] [Abstract][Full Text] [Related]
19. Protection of the cardiovascular system by imidapril, a versatile angiotensin-converting enzyme inhibitor.
Hosoya K; Ishimitsu T
Cardiovasc Drug Rev; 2002; 20(2):93-110. PubMed ID: 12177688
[TBL] [Abstract][Full Text] [Related]
20. Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure.
Goodfield NE; Newby DE; Ludlam CA; Flapan AD
Circulation; 1999 Jun; 99(23):2983-5. PubMed ID: 10368114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
